Michele Colucci is a thought leader in venture capital, a lawyer, an investor, a serial entrepreneur, and a philanthropist. She holds five patents in technology and has established companies across the legal, technology, retail, and entertainment sectors. Her vast experience in highly regulated industries has addressed various issues from management to legal matters. As a venture capitalist specializing in medical technology, Colucci is dedicated to influencing the healthcare field by investing in companies that enhance diagnostic decisions for doctors through AI and big data applications. She has served on the board of directors for public and private companies such as Global Indemnity Group, Nephrosant, Optina Diagnostics, NOWDiagnostics, GLX Analytix, Biotia, and Delphi Diagnostics. Colucci has been a frequent guest lecturer at Stanford University’s School of Engineering. In 2017, she was appointed West Coast Ambassador by the Nobel Laureate Foundation and recognized as one of 'Women of Influence' by the Silicon Valley Business Journal. In 2023, Silicon Valley Magazine honored her as the 'Top MedTech Investor.' Colucci obtained her B.A. and J.D. from Georgetown University and an M.F.A from the AFI.